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Prevention of peritonitis with disconnect systems in CAPD: A
randomized controlled trial.
Background. Recently, disconnect systems for CAPD that are
associated with a reduced frequency of peritonitis have been
introduced. Our objective was to compare the incidence of
peritonitis using three current CAPD systems in a high-risk
population with low educational and socioeconomic levels, and
high prevalence of malnutrition.
Methods. In a prospective controlled trial, 147 patients com-
mencing CAPD were randomly assigned to one of three groups:
29 to the conventional, 57 to the Y-set, and 61 to the twin bag
systems. The number of peritonitis episodes was registered, and
patients were followed up for an average of 11.3 months.
Results. The average peritonitis-free interval for the conven-
tional group was 6.1 months, for the Y system was 12.0 months,
and for the twin bag was 24.8 months (P , 0.001). By multivariate
analysis, the only factor associated with peritonitis was the CAPD
system. Peritonitis-related hospitalization was 5.3 6 2.0, 2.7 6 1.0,
and 1.5 6 0.9 days/patient/year in the conventional, Y system, and
twin bag groups, respectively. The cost per bag was similar for the
conventional and Y system, but higher for the twin bag. However,
the total costs of treatment (pesos/patient/year) were lower for
twin bag (62,159 for the conventional, 70,275 for the Y system,
and 54,387 for the twin bag), due to the lower peritonitis incidence
and associated hospitalizations.
Conclusions. Y system and twin bag use was associated with a
reduction of 50 and 75% peritonitis incidence, respectively, in
patients on CAPD. The cost of the twin bag was actually lower,
because of savings from a decreased usage of antibiotics and fewer
hospitalizations.
Peritonitis and exit site and tunnel infections are the
most frequent causes of morbidity among patients with
end-stage renal disease (ESRD) treated with continuous
ambulatory peritoneal dialysis (CAPD) and in the long
term are the main causes of technique failure [1, 2].
Considerable efforts have been made to reduce infection
rates in CAPD. These include attempts to eradicate Staph-
ylococci from the skin, exit site or nose [3–5], and by
modifying the catheter design [6]; however, improved dis-
connect systems have had the greatest impact. The efficacy
for elimination of contaminating bacteria [7] and reduction
in infection rates [8–10] of disconnect systems with a flush
before the fill design, such as the Y set, with or without
antiseptics have been tested. Recently, a closed twin bag
system that may provide an even greater reduction in
peritonitis episodes has been introduced [11–16].
Peritonitis prevention is crucial so that the viability of the
peritoneal membrane can be preserved [17, 18]. This is
especially important for patients who have high risk factors
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for infectious complications combined with a limited access
to facilities for hemodialysis in cases of technique failure of
peritoneal dialysis (PD). This is true in Mexico, where PD
is the replacement modality used in over 90% of the
patients with ESRD, and the patients have an increased
risk of infection because of a high incidence of diabetes,
poor environmental conditions, and high malnutrition rates
[19–21].
The objective of this study was to compare the efficacy of
different disconnect systems for peritonitis prevention in
patients on CAPD from an unselected population, and to
develop cost-benefit data to support its use.
METHODS
Patients
Patients with ESRD without any previous replacement
therapy were entered into the study. Patients with previous
abdominal surgery, abdominal hernias, diverticulosis, can-
cer or AIDS were excluded. There was no selection by age,
sex, original renal disease or socioeconomic status. After
obtaining informed consent, patients were randomized to
the different study groups. In every patient, a straight
double-cuff Tenckhoff catheter (Accurate Surgical Instru-
ments Corporation, Toronto, Ontario, Canada) was placed.
The implantation technique was that preferred in each
participating center, but the same technique was used in all
the patients within each center. The dialysis regime was as
prescribed by the attending nephrologist. The patients (or
the dialysis partner) received training until it was judged
that the bag exchange technique was learned and properly
applied.
Study design
This was a randomized, prospective open clinical trial.
Patients were randomized into three groups in a ratio of
1:2:2 to the conventional straight-line spike system, the Y
set system or the twin bag system. This randomization ratio
was also maintained within each center. Allocation of the
patients to the groups was done centrally by one of the
researchers (D.A.) following the Moses-Oakford method
as described by Meinert [22], with the use of a list of
random numbers. The order of allocation was sent to each
participant center in sealed envelopes. A copy of the
assignment list was kept in the coordinating center. At least
three audit visits were done to each center by trained
nurses (M.J.V. or A.J.) to certify that the envelopes were
used in the order provided and that their content remained
unknown to the personnel of the center until the initiation
of the treatment. For study purposes the patients were seen
every two months at scheduled visits, but they were allowed
to attend spontaneously at any moment, if dialysis related
problems occurred.
Outcomes
The primary end points were the peritonitis rate, and the
rate of exit site and/or tunnel infection. Peritonitis-free
survival to the first and second episodes of peritonitis was
also measured. The secondary end-points were technique
failure, mortality attributable to peritonitis, days hospital-
ized for peritonitis and for all other causes. Age, gender,
educational level, existence of diabetes, and nutritional
status were analyzed as covariates.
Cost calculations
For cost calculations only expenses generated by dialysis
materials, hospitalization, and antibiotics were taken into
account. Costs related to physicians were not considered
since in all the participant institutions, medical and para-
medical personnel earned fixed salaries. Hence, the costs
related to physician and other health care personnel in-
comes involved in the ambulatory patients’ care were
considered to be the same in all the groups. Regarding
hospitalization, for cost calculation purposes the Instituto
Mexicano del Seguro Social (IMSS) has developed an index
termed “cost per bed per day” that involves all of the costs
generated by the routine care of the patient, including
personnel salaries, excluding the costs of drugs and labo-
ratory examinations. Since nine of the eleven participating
centers belong to the IMSS, we used this index to estimate
hospitalization costs. At the time of the study the cost per
bed per day at IMSS hospitals was 755 Mexican pesos. The
cost of dialysis material was the commercial price as
provided by Baxter, Mexico. All the antibiotics used during
the research were paid by a special fund of the study. The
antibiotic costs considered were the actual purchasing
prices. Costs of other treatments not related to peritonitis
were not determined, but were considered to be similar
among the groups.
Definitions
Peritonitis was defined as the occurrence of two of the
following findings: abdominal pain, cloudy dialysate, cell
count higher than 100 cells/ml, or dialysate positive culture.
Relapse was defined as the occurrence of new peritonitis
signs or symptoms occurring within one month after a
previous peritonitis episode, with or without bacteriologic
confirmation of the same microorganism. Tunnel or exit-
site infections were defined as the occurrence of pain,
edema and/or erythema of the skin over the tunnel, or
purulent secretion at the exit site of the catheter. Malnu-
trition was defined as the presence of serum markers
(albumin, prealbumin and transferrin) lower than two SDs
from the mean of normal population values. Samples for
bacteriologic studies were collected in duplicate in aerobic
blood culture bottles (Pedi-BacT; Organon, Teknika Corp.
Durham, NC, USA). One bottle was cultured in the
laboratory of the participating center and the other was
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sent to a central reference laboratory (Unit of Medical
Research on Infectious and Parasitic Diseases, Hospital de
Pediatrı´a, Centro Me´dico Nacional Siglo XXI, IMSS, Mex-
ico City). Initial treatment for peritonitis was the standard
recommended therapy with vancomycin and amikacin [23],
and was modified if required according to the isolated
microorganism(s).
Nutritional status
For every patient, serum albumin, prealbumin and trans-
ferrin levels were determined by nephelometry [24] in a
central reference laboratory (Unit of Medical Research on
Nephrologic Disesases, Hospital de Especialidades, Centro
Me´dico Nacional Siglo XXI, IMSS, Mexico City).
Statistical analysis
For continuous variables, the differences among groups
were assessed with ANOVA. For discontinuous variables,
the Mann-Whitney U-test, median test or x2 test was used.
To control the covariates, a multiple logistic regression was
performed. The time of first and second peritonitis-free
survival was analyzed by Kaplan-Meier curves with the
log-rank test. All these statistics were done with the SPSS
program (SPSS for Windows, version 6.0). The incidence of
peritonitis was analyzed with a Poisson-based regression
using the mixed-effects gamma-Poisson model [25]. Differ-
ences were considered significant if P values were less than
0.05.
RESULTS
One hundred and fifty-four patients entered the random-
ization phase, and 147 began the study. The number of
patients in each group was as follows: conventional 29, Y
system 57, and twin bag 61. The groups were comparable in
age, gender, and frequency of diabetes mellitus (Table 1).
A high prevalence of malnutrition was found, with no
differences among the three groups (Table 1). Sixty-five
percent of the patients were under the third percentile for
serum albumin. A group of healthy and well-nourished
Mexican individuals was taken as standard reference.
There were 55 peritonitis episodes in 20 patients from
the conventional group, 57 episodes in 35 patients from the
Y system group, and 26 episodes in 18 patients from the
twin bag group. The percentage of patients with at least one
peritonitis episode was lower in the twin bag group than in
the conventional or Y system groups; the average perito-
nitis-free intervals were significantly different among the
three groups (Table 2).
Figure 1 shows the Kaplan-Meier curve of the first
peritonitis-free survival time. There were significant differ-
ences between the conventional group and the twin bag
group, and between the Y system group and the twin bag
group (P , 0.001). Figure 2 shows the Kaplan-Meier curve
of the second peritonitis-free survival time, with significant
differences between the conventional group and the Y
system group (P , 0.001) and between the Y system group
and the twin bag group (P , 0.025).
A logistical regression analysis was carried out consider-
ing either all peritonitis episodes, or the first or the second
peritonitis episode alone as the dependent variable, and
age, sex, diabetes mellitus, self-care capacity for manage-
ment of the procedure, and nutritional marker proteins as
independent variables. None of the variables analyzed had
any effect on average peritonitis-free intervals, irrespective
Table 2. Episodes of peritonitis
Disconnect
system
Patients Peritonitis Follow up
Time at risk per
patient
Patients with at
least 1 peritonitis
Average
peritonitis-free
interval
monthsN months N %
Conventional 29 55 337.4 11.6 20 69.0 6.1
Y system 57 57a 670.8 11.8 35 61.4 12.0a
Twin bag 61 26a,b 645.1 10.6 18a,b 29.5 24.8a,b
a P , 0.01 vs. conventional
b P , 0.01 vs. Y system (mixed-effects gamma-Poisson model)
Table 1. Demographics of the three study groups
Disconnect
system N
Age
years
Sex
M/F
Weight
kg
SCr
mg/dl
Diabetes
mellitus
BP (S/D)
mm Hg
Albumin Prealbumin Transferrin
g/liter
Conventional 29 39.7 15/14 57.2 10.10 11/29 141 6 28 21.76 0.217 2.24
6 19.0 6 16.2 6 4.52 83 6 16 6 6.59 6 0.017 6 0.39
Y system 57 43.2 37/20 59.3 11.54 19/57 142 6 27 20.24 0.211 2.18
6 21.3 6 17.7 6 5.40 88 6 16 6 7.61 6 0.026 6 0.48
Twin bag 61 43.6 33/28 57.1 11.83 20/61 136 6 22 22.58 0.212 2.23
6 21.9 6 19.6 6 5.45 88 6 20 6 8.06 6 0.023 6 0.44
Values are mean 6 SD. Abbreviations are: SCr, serum creatinine; BP, blood pressure; S/D, systolic/diastolic.
There were no significant differences among groups.
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of inclusion or non-inclusion of the disconnect system in
the model.
Seventy-two percent of the dialysate cultures were posi-
tive. From these, Staphylococci were present in 65%. A
lower frequency of peritonitis by S. aureus and S. epidermi-
dis was seen in the Y system and twin bag groups when
compared with the conventional group. A significant dif-
ference in S. epidermidis infections in the twin bag group
was also noted (Table 3).
There were 58 episodes of exit site tunnel infections, 23
of them simultaneous with peritonitis episodes, and the
causal agent was identified only in a few cases. Thirty-six
catheters were replaced, 8 in the conventional group, 14 in
Y system group, and 14 in the twin bag group; these
numbers were not significantly different. In six cases tunnel
infection was the cause of catheter loss: 3 in the conven-
tional group, 2 in the Y system group, and 1 in the twin bag
group. There were no statistical differences among them.
Ten patients dropped out of the study because they
received a renal allograft. Another 23 dropped out due to
death, 8 due to technique failure, and 11 for miscellaneous
causes. The causes of death were cardiovascular in 13,
infections not related to peritonitis in 6, and miscellaneous
in 4. There were no significant differences in drop out or
deaths among the groups.
Table 4 shows the peritonitis-related and non-related
numbers and days of hospitalization. The Y system group
was significantly different from the conventional group, and
the twin bag group from the Y system group. Table 5 shows
some cost data. The cost per bag was the same for
conventional and basic Y systems and slightly higher for the
twin bag. However, the usage of other materials such as
gauze, caps, masks, clamps, adhesive tape, and antiseptics
made the cost higher per exchange in the conventional and
Y system groups. Additionally, the total treatment costs per
patient per year were further reduced in the twin bag group
due to the lower rate of peritonitis and related hospitaliza-
tions.
DISCUSSION
Since the introduction of CAPD in 1978 [26], the number
of patients receiving this modality of treatment has shown
a steady increase around the world. The proportion of
Fig. 1. Kaplan-Meier survival analysis of first peritonitis-free intervals.
The twin bag group had a longer survival than the conventional and Y
system groups (P , 0.001 by log-rank test). No differences were found
between the conventional group and the Y system group.
Fig. 2. Kaplan-Meier survival analysis of second peritonitis-free inter-
vals. The conventional group had a significantly shorter survival than the
Y system group (P , 0.001 by log-rank test), and the Y system group had
a significantly shorter survival than the twin bag group (P , 0.025).
Symbols are: (F) conventional group; (f) Y system group; () twin bag
group.
Table 3. Comparison of positive dialysis cultures
Disconnect
system
Positive cultures for
Staphylococcus
aureus
Positive cultures for
Staphylococcus
epidermidis
%
Average
peritonitis-free
interval
months %
Average
peritonitis-free
interval
months
Conventional 42.2 10 27.3 22
Y system 32.0 37a 40.0 29a
Twin bag 33.3 72a,b 11.1 215a,b
a P , 0.01 vs. conventional
b P , 0.01 vs. Y system (mixed-effects gamma-Poisson model)
Table 4. Hospitalizations
Disconnect
system
Patients
N
Hospitalization
peritonitis-
related
Hospitalization
peritonitis-
unrelated Hospitalization
hospitalizations/
patientdays/patient/year
Conventional 29 5.3 6 2.1 10.6 6 3.1 2.1 6 0.4
Y system 57 2.7 6 1.1a 7.3 6 1.5 1.6 6 0.2
Twin bag 61 1.5 6 0.9a,b 14.6 6 5.8 1.7 6 0.4
Values are mean 6 SEM.
a P , 0.01 vs. conventional (median test)
b P , 0.01 vs. Y (median test)
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patients with ESRD using CAPD varies strikingly from one
country to another. In Mexico, over 90% of the patients
with ESRD receive peritoneal dialysis, and more than 50%
of them are on CAPD [19, 20]. The costs of management of
the patients with ESRD are among the major economic
burdens that the health care institutions have to bear. Thus,
it is of the utmost importance to develop and to incorporate
into routine management all of the technical improvements
that may reduce complications in the patients on CAPD.
Our results show a considerable advantage of the Y set
system and more especially of the twin bag system over the
conventional system, for preventing peritonitis in patients
on CAPD. The difference in efficacy of the disconnect
systems in preventing peritonitis was still evident in spite of
the presence of risk factors such as malnutrition, diabetes,
and unfavorable socioeconomic conditions [20, 21].
Modifications of the CAPD systems began in the 1980s.
The efficacy of disconnect systems to eliminate bacteria has
been proven in vitro [7], and in clinical studies their use has
been associated with lower rates of peritonitis [8–16].
However, few clinical studies have the methodological rigor
of the controlled clinical trials [14, 16], and in none of them
tested the disconnect systems in patients at high risk for
developing peritonitis.
For the conventional spike system the peritonitis-free
intervals found in this work are similar to those reported in
other studies. For the Y set system and twin bag system, the
peritonitis-free intervals are somewhat shorter than those
reported in other studies, perhaps because comorbidity in
our patients was different.
According to the contamination mechanism suggested to
explain peritonitis, a significant change in microbial etiol-
ogies was expected. In this and in other studies, a reduction
in the coagulase-negative Staphylococcal infection rate was
associated with the new disconnect systems [10, 27]. How-
ever, this is not a general finding [16]. The prevalence of
nasal carriage of Staphylococcus among ESRD patients and
healthy subjects in Mexico is unknown. No measures were
undertaken to try to eradicate Staphylococcus in the pa-
tients included in the study.
Malnutrition among our patients had a higher preva-
lence than that reported in the international literature, but
was similar to the prevalence found in previous Mexican
studies [21, 28]. Malnutrition produces negative effects on
different aspects of the immune response, some of them of
great relevance for peritonitis risk. However, in these
patients, none of the nutritional markers were associated
with peritonitis, suggesting that malnutrition is not an
independent risk factor for the development of infections.
Of all published papers on the new disconnect systems,
only one addresses the issue of cost-benefit analysis [16].
The authors concluded that closed systems have a higher
purchase cost, but savings from the lower incidence of
peritonitis offset this expense.
In our study, the costs of physician care are not pre-
sented. Most of the participant centers in this study belong
to the IMSS. This institution provides a wide insurance
system (medical care, treatment, rehabilitation and work-
ing incapacity insurance) to 50% of the Mexican population
[20]. Medical staff and other health personnel in the IMSS
earn fixed salaries. The other two participant institutions
have a similar payment system to their physicians and
health personnel. In this regard, salaries are fixed in an
hours/day basis irrespective of regional differences, medical
specialty or number of patients seen. Therefore, costs for
an individual patient are not available. Costs of hospital-
ization were calculated using an index that represents a
national average of the IMSS, for similar reasons. In spite
of these methodological limitations, it is clear that the new
systems are less expensive due to the lower cost per
exchange, the reduction in the number of peritonitis epi-
sodes, as well as the expenses generated by diagnostic tests,
antibiotics and especially by hospitalization. The reduction
in the peritonitis rate itself is sufficient to justify the use of
the new systems, but in the longer term it may have
enormous importance, because repeated infections may
Table 5. Comparison of costs for the three dialysis systems
Disconnect
system
Catheter installation
pesos/patienta
Exchange
pesos/exchangea Cost breakdown Total cost
Device Consumables Bag Others pesos/pt/yra
Conventional 648.93 83.40 31.14 8.35 57,916 M 62,159
2,873 H
1,370 P
Y system 648.93 131.63 31.14 14.73 67,467 M 70,275
2,094 H
714 P
Twin bag 648.93 144.26 36.00 0.00 53,078 M 54,387
970 H
338 P
Definitions are: Device, catheter, titanium connector; Consumables, transfer line, clamps; M, materials (bags, antiseptic, gauze, caps, masks, clamps,
adhesive tape); H, hospitalization; P, peritonitis (antibiotics).
a Costs were calculated in Mexican pesos
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reduce the capacity of peritoneum for dialysis [17, 18]. The
impact of this effect cannot be measured with the present
data, but it is of indubitable importance in the face of the
limited availability of hemodialysis and transplantation in
Mexico.
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